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Mouse embryonic stem (ES) cells grown in serum
exhibit greater heterogeneity in morphology and
expression of pluripotency factors than ES cells
cultured in defined medium with inhibitors of two
kinases (Mek and GSK3), a condition known as ‘‘2i’’
postulated to establish a naive ground state. We
show that the transcriptome and epigenome profiles
of serum- and 2i-grown ES cells are distinct. 2i-
treated cells exhibit lower expression of lineage-
affiliated genes, reduced prevalence at promoters
of the repressive histone modification H3K27me3,
and fewer bivalent domains, which are thought to
mark genes poised for either up- or downregulation.
Nonetheless, serum- and 2i-grown ES cells have
similar differentiation potential. Precocious tran-
scription of developmental genes in 2i is restrained
by RNA polymerase II promoter-proximal pausing.
These findings suggest that transcriptional potentia-
tion and a permissive chromatin context characterize
the ground state and that exit from it may not require
a metastable intermediate or multilineage priming.
INTRODUCTION
Mouse embryonic stem (ES) cells are characterized by the
potency to generate all somatic and germline lineages in vitro
and in chimaeric embryos (Smith, 2001). The nature of the
transcriptional and epigenetic machinery that maintains this
potential throughout massive in vitro expansion has been the
subject of intense investigation (Young, 2011). Interest is further
heightened by appreciation that knowledge of the molecular
underpinning of mouse ES cells may enable derivation of
equivalent human naive pluripotent stem cells (Hanna et al.,
2010).
ES cells are described as transcriptionally hyperactive (Efroni
et al., 2008). Promiscuous transcription has been suggested to590 Cell 149, 590–604, April 27, 2012 ª2012 Elsevier Inc.constitute a platform for lineage specification (Loh and Lim,
2011). When taken together with the observation that several
pluripotency factors are expressed heterogeneously (Chambers
et al., 2007; Niwa et al., 2009; Toyooka et al., 2008), the notion
has arisen that pluripotency may inherently be a metastable
condition (Graf and Stadtfeld, 2008; Hanna et al., 2009; Hayashi
et al., 2008). Attention has also been drawn to colocalization
at many promoters of histone 3 lysine 4 trimethylation
(H3K4me3), associated with transcriptional activation, and
histone 3 lysine 27 trimethylation (H3K27me3), linked with
repression (Azuara et al., 2006; Bernstein et al., 2006; Stock
et al., 2007). These bivalent domains are posited to be poised
for either up- or downregulation and to provide an epigenetic
blueprint for lineage determination.
The preceding views are based on analyses of ES cells
cultured in serum and therefore subject to uncontrolled multifac-
torial perturbations. It is now possible to derive and maintain
pluripotent mouse ES cells without serum factors by using two
small molecule kinase inhibitors (2i) in combination with the
cytokine leukemia inhibitory factor (LIF) (Ying et al., 2008). The
2i inhibitors, PD0325901 and CHIR99021, selectively target
mitogen-activated protein kinase kinase (Mek) and glycogen
synthase kinase-3 (Gsk3), respectively. The inhibitors shield
pluripotent cells from differentiation triggers: fibroblast growth
factor-4 stimulation of the Mek-Erk pathway and endogenous
repressor activity of Tcf3 (Kunath et al., 2007; Wray et al.,
2011). Use of 2i has enabled derivation of germline-competent
ES cells from all mouse strains tested and for the first time
from rats (Buehr et al., 2008; Hanna et al., 2009; Kiyonari et al.,
2010; Li et al., 2008; Nichols et al., 2009). 2i thus provides
a better-tuned environment for rodent ES cells. Indeed, the
mosaic expression of pluripotency factors observed in serum
is effectively eliminated in 2i (Wray et al., 2011). Furthermore,
culture in 2i may mimic the environment in the mature mouse
inner cell mass (ICM) where the fibroblast growth factor receptor
is downregulated in the epiblast (Guo et al., 2010).
Here we applied massively parallel sequencing technology to
characterize the global transcriptome and to map selected
histone modifications in naive mouse ES cells maintained in 2i
compared with heterogeneous cultures in serum.
RESULTS
Transcriptome Analysis
Three ES cell lines derived and maintained in 2i plus LIF (‘‘2i’’ ES
cells) were compared with three ES cell lines established and
cultured in serum plus LIF (‘‘serum’’ ES cells) (Tables S1 and
S2). Each cell line is functionally pluripotent as demonstrated
by competence to generate high-contribution chimaeras with
germline transmission. Expression values from RNA-seq data
were calculated by quantifying the number of sequence reads
for each gene with standardized RPKM values (reads per kilo-
base of exon model per million mapped sequence reads). This
comparison showed that 1,489 genes have more than 2-fold
higher transcript abundance in 2i (p value < 0.2), whereas
1,947 genes exhibit more than 2-fold higher expression in serum
(Figure 1A). Moreover, 160 genes expressed in 2i (RPKM > 0.5)
were silent in serum (RPKM < 0.2) and 461 genes were ex-
pressed only in serum (Figure S1A and Table S3 available online).
The majority of categorized stem cell maintenance genes ([SCM]
GO:0019827), including validated core pluripotency factors,
Pou5f1,Nanog, Sox2, Esrrb,Klf2,Klf4, and Tbx3, are transcribed
to similar levels in 2i and serum (Figure 1B and Figure S1B). Nine
SCM genes are more highly expressed in 2i (Figure 1B and Fig-
ure S1C). Of these, only Tcl1 has been implicated as a regulator
of self-renewal (Ivanova et al., 2006), and although this transcript
is more abundant in 2i, it is also well-expressed in serum. In
serum, 16 SCM genes showed higher expression. Factors in
this group, such as c-Myc and the Id proteins, are known to be
induced by Erk signaling and by serum. They may confer addi-
tional robustness to the pluripotent state to counter differentia-
tion stimuli (Ying et al., 2003a). Interestingly, several of these
genes are induced when ICM cells are explanted in medium
containing serum (Figure S1D; Tang et al., 2010).
Functional annotation clustering of differentially expressed
genes by Gene Ontology ([GO] PANTHER [protein analysis
through evolutionary relationships]) and Pathway (KEGG [Kyoto
encyclopedia of genes and genomes]) analysis (Figure 1C) re-
vealed that genes upregulated in 2i are highly enriched for terms
associated with metabolic processes. This is probably in part
a direct consequence of inhibition of Mek and Gsk3 and the
absence of serum constituents. Reduced c-Myc may further
affect metabolic networks. Major differences are also apparent
for genes involved in cell-cycle regulation. Proliferation is similar
in the two conditions (Ying et al., 2008), however, reflecting the
absence of G1 restriction in ES cells.
Upregulated genes in serum are significantly enriched for GO
terms linked to developmental processes, particularly ectoderm
andmesoderm germ layer specification (Figure 1C). Genes such
as Pax6, T (Brachyury), and Runx1 show very low or undetect-
able expression in 2i but appreciable transcription in serum
(Figure 1D). Other ectoderm and mesoderm marker genes
such as Runx3, Sox18, Cdx4, and Tal1 are also activated in
serum, although only to low levels. In contrast, several genes
associated with the germline or with endoderm are expressed
at similar levels in both conditions.
ES cells maintained in 2i are morphologically uniform and
rather homogeneous in expression of pluripotency regulators
(Wray et al., 2010). In contrast, serumES cells are heterogeneousin morphology (Figure S2A) and expression of factors such as
Nanog, Rex1, Stella, and Klf4 (Chambers et al., 2007; Hayashi
et al., 2008; Toyooka et al., 2008; Figure S2B). In serum, ES cells
with a mono-allelic green fluorescent protein (GFP) knockin at
the Rex1 (Zfp42) locus comprise GFP-positive and -negative
populations that can be separated by flow cytometry (Fig-
ure S2C; Wray et al., 2011). These populations are functionally
distinct. Rex1GFP-positive cells plated in serum generate
colonies of undifferentiated cells, whereas Rex1GFP-negative
cells produce predominantly small, differentiated colonies
(Figure S2D). On plating in 2i, the yield of ES cell colonies in
Rex1-positive cells is more than 10 times that in Rex1-negative
cells. Rex1-negative cells have therefore largely lost clonogenic
self-renewal capacity. Consistent with this, although they
express Oct4, they lack Nanog and Klf4 (Figure S2E). All
Nanog-positive and almost all Klf4-positive cells are within the
Rex1GFP-positive fraction. Expression is still mosaic within
this population, reflecting transcriptional fluctuation (Chambers
et al., 2007; Kalmar et al., 2009; Figure S2E). In contrast, ES
cells in 2i are almost uniformly positive for Rex1, Klf4, and Nanog
(Wray et al., 2010; Figure S2B). We examined the transcriptome
of the Rex1-positive fraction in serum and found a similar
increased expression of a subset of SCM genes as in bulk ES
cells (Figure 1B). Some ectoderm- and mesoderm-associated
genes were also upregulated compared with expression in 2i
ES cells but others showed little induction (Figure 1D). In general,
differentiation genes were more highly expressed in Rex1GFP-
low cells (Figures S2F–S2H). Nonetheless, transcriptomes of
the Rex1-positive compartment in serum showmany differences
from 2i ES cells (Figure S2I). Notably, many genes that show
higher expression in 2i are not upregulated in Rex1-positive
serum ES cells (Figure 1B). Therefore it is unlikely that a sub-
population of serum cells persist in an equivalent state to 2i.
Transcriptome Interconversion
To assess whether the distinct gene expression patterns in 2i
and serum represent ‘‘fixed’’ transcriptional states, we trans-
ferred 2i cells to serum and vice versa. Within two to three
passages, cultures adopted morphological characteristics of
the new condition. We carried out RNA-seq analyses after eight
passages.Most of the SCMgenes that showed lower expression
in 2i were upregulated in serum, whereas transcripts elevated in
2i were downregulated (Figure 2A red dots and black squares,
respectively). Reciprocal behavior was observed when serum
cells were transferred to 2i (Figure 2B). Furthermore, genes
involved in ectoderm and mesoderm germ layer specification
were broadly upregulated after transfer of 2i cells to serum and
the reverse transcriptional changes were observed when serum
cells were passaged in 2i (Figures 2A and 2B, blue stars). Typical
examples are shown in Figure 2C. Irrespective of the direction of
exchange between 2i and serum, 818 genes were expressed
more highly (>2-fold) in 2i and 1,209 showed higher levels in
serum (Figure 2D). GO classification identified developmental
genes and cell-cycle control genes as highly enriched upon
transfer to serum, whereas genes upregulated in 2i were mainly
associated withmetabolic categories (Figure 2E). The reciprocity
in transcriptome changes demonstrates that the transcriptional
profiles are interconvertible.Cell 149, 590–604, April 27, 2012 ª2012 Elsevier Inc. 591
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Histone Modification Profiles
We performed chromatin immunoprecipitation and deep se-
quencing (ChIP-seq) to analyze posttranslational histone modi-
fications: H3K4me3 and H3K36me3 associated with active
promoters and transcribed genes, respectively; H3K27me3
linked to silencing, and H3K9me3 associated with constitutive
heterochromatin and imprinted genes (Table S1). We also
analyzed the polycomb repressor complex 2 (PRC2) component
Ezh2 that methylates H3K27 (Cao et al., 2002).
Determination of average profiles over 2,000 genes that are
most highly expressed in both conditions (Figure 3A and Fig-
ure S3A) revealed conventional distribution of H3K4me3 on
active promoters and of H3K36me3 extending over the coding
body. The H3K9me3 ChIP-seq state maps of 2i and serum cells
were nearly identical. In both conditions deposits were most
prominent at satellites and imprinted genes (Figures S3B–S3E).
As expected, the H3K27me3 mark is absent from actively tran-
scribed loci (Figure 3B). It appears to be mutually exclusive with
H3K36me3 (Figures 3A–3C and Figure S3F), in line with recent
biochemical data showing thatPRC2activity is inhibitedbyactive
marks including H3K36me3 (Schmitges et al., 2011). However,
H3K27me3 is widely deposited over intergenic regions and
inactive genes at levels appreciably higher than random distribu-
tion. This lawn of H3K27me3 is qualitatively and quantitatively
similar in 2i and serum ES cells (Figure 3C). A pronounced differ-
ence is apparent only at promoters of lowly expressed genes
(Figure 3B). The averaged profile of these promoters showed
markedly less H3K27me3 in 2i than in serum. This was not
reflected in any overall increase in expression (Figure S3H). Three
independent 2i ES cell lines exhibited a significantly reduced
level of H3K27me3 at the promoters of poorly or nonexpressed
genes compared to the level in serum cultures (Figure 3D). To
investigate whether differences in H3K27me3 deposition
reflected heterogeneity in serum, we performed H3K27me3
ChIP-seq on Rex1-positive and Rex1-negative serum subpopu-
lations. Intriguingly, the H3K27me3 signals were very similar,
each resembling the total serum ES cell population (Figure 3E).
Intensity plots covering a region of 5 kb up- and downstream
of all promoters that are decorated with H3K27me3 in serum
demonstrate the major reduction in H3K27me3 in 2i cells (Fig-
ure 3F). Ezh2 levels were also diminished at these locations in
2i. In either condition, the H3K27me3 pattern follows a camel-
back profile with a depleted region around the transcriptional
start site. Ezh2 appears as a single peak centered on this trough.
Representative examples of differential H3K27me3 profiles are
shown in Figure 3G (Figure S3I shows the PCR validation). The
Gata6, Pax9, and Lhx1 genes are barely expressed in either 2i
or serum, but in all cases the H3K27me3 signal around theFigure 1. Transcriptome Profiling of ES Cells in 2i and Serum
(A) Fold change (log2 values) in transcript level of all genes in 2i versus serum. Ge
(TNGA, NOD_male, and NOD_female) or serum (E14, XT67E1, and RGD2) were
the dotted line. The corresponding heatmap is shown at the bottom. For the rem
a p value < 0.2 (Student t test).
(B) RNA-seq levels of a selection of pluripotency, self-renewal, and stem cell m
Rex1-positive serum ES cell population as collected by FACS (Figure S2C) are in
(C) Functional annotation analysis of the differentially expressed genes between
(D) Transcript level of genes associated with the various germ layers.
See also Figure S1, Figure S2, Table S1, Table S2, and Table S3.promoter is selectively and greatly reduced in 2i. For the Lhx1
locus, adjacent Aatf provides a contrasting example of a gene
that is productively transcribed in both 2i and serum and remains
devoid of H3K27me3 in either condition.
Given the interchangeable transcriptome profiles between 2i
and serum, we examined the epigenomic landscape in ES
cells transferred between the two conditions. Cells taken from
2i into serum acquired substantially elevated H3K27me3 at
H3K27me3-associated promoters (Figure 3H), the Hox clusters
(Figure S4A), and many other loci (Figure S4B). Conversely,
serum ES cells transferred into 2i displayed diminished
H3K27me3 at these loci. Ezh2 and Suz12 localization similarly
switched between culture conditions (Figure 3H and Figures
S4A and S4B). Therefore these epigenomic states are
interconvertible.
H3K27me3 was reduced by between 63%–75% over all Hox
clusters in 2i (Figure 3G and Figure S4A). The Hoxc locus
follows this pattern but with a distinctive variation; in the
Hoxc13-c12 region H3K27me3 deposition is lost entirely. This
region (boxed in Figure 3G) is transcribed only in 2i. Strand-
specific RNA-seq profiling after rRNA depletion revealed two
nonoverlapping transcripts on the reverse and forward strand
(both boxed in Figure S4C, left). These ncRNAs are distinct
from the HOTAIR ncRNA located between HOXC11-12 in
human (Rinn et al., 2007). Consistent with recent findings
(Guttman et al., 2010), we detected known as well as multiple
previously unidentified ncRNAs. Many of these, such as H19,
showed differential expression between 2i and serum (Fig-
ure S4C and Table S4).
Global Redistribution of H3K27me3
We computed the number of H3K27me3 reads over nonrepeti-
tive regions and plotted the frequency of occurrence and the
genomic location. In 2i, high H3K27me3 deposition is scarce
with very little enrichment at promoters. In contrast, in serum
H3K27me3 is elevated at many genomic locations, 60%–65%
of which are promoters (Figures 4A and 4B). In 2i, H3K27me3
is somewhat reduced over long interspersed nuclear element
(LINE) repeats (Figure 4C). This is more than offset, however,
by much higher levels of H3K27me3 present at satellites. Immu-
noblotting showed that the total cellular level of H3K27me3 is
comparable in 2i and serum (Figure 4D), confirming that the
differences at promoters are not secondary to a general reduc-
tion in H3K27me3 deposition in 2i.
H3K27me3 is deposited by PRC2 and facilitates recruitment
of the PRC1 complex. Transcripts of PRC2 and PRC1 subunits
were present at similar levels in 2i and serum (Figure S5A).
Transcripts for the H3K27me3 demethylases Kdm6a andne expression values of three ES cells lines derived and maintained in either 2i
averaged, after which ratios were calculated. A 2-fold change is indicated by
aining analysis, an extra constraint for differential gene expression was set by
arkers for 2i and serum ES cells as shown in (A). Expression values for the
cluded.
2i and serum ES cells.
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Figure 2. Expression Profiles of 2i and Serum ES Cells Are Interconvertible
(A and B) Comparison of expression of pluripotency and lineage-specific genes (as shown in Figures 1B and 1D) for TNGA cells adapted from 2i to serum (A) and
E14 adapted from serum to 2i (B).
(C) Typical examples of genes that show transcriptional interconvertibility.
(D) Number of genes that show interconvertibility (>2-fold difference between both 2i and serum conditions).
(E) Functional analysis of the differential genes shown in (D), the genes consistently higher in either 2i or serum.
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Kdm6b (also known as Utx and Jmjd3) were also comparable.
Ezh2 immunoblotting indicates slightly lower protein in 2i
than in serum (Figure S5B). However, phosphorylation of
Ezh2 at Thr345, reported to be important for PRC2 recruitment
(Kaneko et al., 2010), is similar (Figure S5C). Collectively,
these data suggest that the difference in H3K27me3 occu-
pancy at silent promoters in 2i is not primarily attributable to
reduced expression of polycomb nor to altered demethylase
expression.
Bivalency
Promoters that are marked by H3K27me3 may also display
H3K4me3. Such bivalent genes are thought to be poised for acti-
vation (Azuara et al., 2006; Bernstein et al., 2006; Mikkelsen
et al., 2007). We binned and ranked promoters according to
the read density for H3K27me3 (Figure 5A) measured in serum
and assessed whether bivalency is preserved in naive ES cells.
Applying similar filters and thresholds as used by Mikkelsen
et al. (2007), we classified almost 3,000 genes as bivalent in
serum (Figure 5B, upper, and Table S5). In 2i, due to the reduced
deposition of H3K27me3, many of these genes fall below
the threshold, resulting in less than 1,000 genes that qualify as
bivalent (Figure 5B, lower). Intensity plots show the general
and pronounced diminution in H3K27me3 deposition, whereas
H3K4me3 is only slightly altered (Figure 5C). Figure S6A docu-
ments the levels of mRNA, H3K27me3, and H3K4me3 in 2i
versus serum. Notably, the profiles interconvert upon switching
cells between serum and 2i (Figures S6B and S6C).
In both serum and 2i, the bivalent genes are enriched for
involvement in developmental processes. Representative ex-
amples are the mesoderm specification marker Hey2 and ecto-
dermal Metrnl (Figure 5D). Transcripts are barely detectable
in 2i, although H3K4me3 is present and H3K27me3 is low. In
serum, transcription is slightly upregulated even though the
promoters show a broad gain of H3K27me3. A significant
proportion of genes with bivalent promoter marking (31%)
exhibit only background transcription in either condition
(RPKM < 0.2). However, 14% of the bivalent genes are serum
specific (RPKM > 0.5 in serum; RPKM < 0.2 in 2i), whereas
a minor fraction (4%) are expressed only in 2i.
In either serum or 2i, H3K27me3 does not colocalize precisely
with H3K4me3 but accumulates on either side of the H3K4me3
peak at the transcription start site (Figure 5C). This is consistent
with observations that targets of TrxG proteins, which methylate
H3K4, show reduced H3K27 methylation (Papp and Mu¨ller,
2006; Srinivasan et al., 2008) and that PRC2 activity is inhibited
by active marks, including H3K4me3 (Schmitges et al., 2011).
Strikingly RNA polymerase II (Pol II) is evident over transcription
start sites at higher levels in 2i than in serum (Figure 5C), sugges-
tive of promoter proximal pausing.
Influence of c-Myc
c-Myc is implicated in Pol II pause release (Rahl et al., 2010). We
previously noted a very low level of c-Myc protein in 2i (Ying
et al., 2008). The RNA-seq data show that c-myc mRNA is 40-
to 50-fold lower in 2i than in serum and n-myc and l-myc are
also reduced (Figure 1B).We analyzed c-Myc targets that are up-
regulated in serum (Figure 6A and Figure S7A). Averaged profilesshow that promoters of these genes are loaded with H3K4me3
and Pol II in 2i. In serum, Pol II is reduced at the promoters and
increased over coding bodies. The Pol II traveling ratio is accord-
ingly increased (Figure 6B), consistent with c-Myc acting as
a pause release factor in serum. Typical examples are Npm1
and Ncl (Figure 6C).
We assessed to what extent global differences in transcrip-
tome between 2i and serum might be related to c-Myc. Several
differentially expressed genes are c-Myc targets, notably cell-
cycle regulators (Figures S7B and S7C). These include cdk/cy-
clinD components that are positively regulated by Myc and are
increased in serum, and conversely cell-cycle inhibitors,
p16(Ink4A), p19(Arf), and p21 that are repressed by Myc and up-
regulated in 2i (Figure S7D). Overall, however, direct c-Myc
targets as determined by Chen et al. (2008) represent less than
15% of genes differentially expressed between 2i and serum
(Figure 6D). Furthermore, gene ontology classification of c-Myc
targets upregulated in serum did not identify categories associ-
ated with developmental processes. Therefore Myc is unlikely
to be a major determinant of differential expression and
metastability.
RNA Polymerase II Pausing
We evaluated the average histone modification profile of all
genes that change expression more than 2-fold in 2i versus
serum. Genes upregulated in 2i show the expected increased
H3K4me3 deposition at the promoter and higher levels of
H3K36me3 in the coding body than in serum (Figure 6E and Fig-
ure S7E). The repressive mark H3K27me3 is correspondingly
reduced. Upregulated genes in serum also show an increase in
H3K36me3 over the coding body but in general do not exhibit
a significant change in H3K4me3 deposition. More remarkably,
on average they show increased H3K27me3.
We then examined Pol II occupancy at these two groups of
genes. This showed that upregulation in 2i is reflected in elevated
Pol II over the transcriptional start site as well as the coding body
(Figure 6F, left). In contrast, genes upregulated in serum showed
increased Pol II over the coding body but also on average
a reduced signal at the start site (Figure 6F, right). These features
indicate that transcriptional elongation at genes already loaded
with Pol II is a widespread mechanism of upregulation in serum.
RNA-seq data reveal no overt differences in expression of pTEFb
components or known regulators of pausing between 2i and
serum (Figure S7F). Regulation at the protein level may therefore
control differential promoter proximal pause release in naive and
metastable ES cells.
Multilineage Differentiation
ES cells maintained in either 2i or serum can colonize the mouse
embryo, demonstrating that they are functionally pluripotent.
However, they differ markedly in transcription of ectodermal
and mesodermal specification genes. The precocious transcrip-
tion of lineage-associated genes, often termed lineage priming
(Hu et al., 1997), is posited to poise stem cells for differentiation.
We therefore compared the differentiation behavior of ES cells
maintained in 2i or serum. We first used a monolayer neural
induction protocol with Sox1GFP reporter ES cells to quantify
differentiation (Ying et al., 2003b). Although ES cells maintainedCell 149, 590–604, April 27, 2012 ª2012 Elsevier Inc. 595
Figure 3. H3K27me3 Is Greatly Diminished at Promoters of Silent Genes and at Hox Clusters in 2i
(A) Average H3K4me3 and H3K36me3 profiles of the 2,000 most active (left plots) and 2,000 silent genes (right plots) from 10kb to +10kb at the transcription
start site and the transcription stop. The negative control (genomic DNA) is shown in Figure S3B.
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Figure 4. Localization and Quantification
of H3K27me3 in 2i and Serum
(A) Binning of H3K27me3 -enriched regions in 2i
and serum according to tag densities per peak (in
reads/kb). The calculated genomic background is
5 reads/kb per 10 million mapped sequence reads
(see Experimental Procedures).
(B) Genomic distribution of H3K27me3 peaks in 2i
(left) or serum (right) per bin as shown in (A).
(C) Percentage of H3K27me3 reads present in the
major repeat categories.
(D) Immunoblot analysis of histone modifications
in total cell extracts.
See also Figure S5.in serum express several neuroectodermal genes, they were
less efficient in generating Sox1GFP-positive neural precursors
than ES cells taken from 2i (Figure 7A). This could be due to
the presence of cells already biased toward a mesodermal fate
in serum. Clearly pre-expression of neural genes in serum does
not predispose to this fate. We then used Rex1GFP fractionation
to compare ES cell subpopulations in serum with 2i ES cells in
embryoid body (EB) differentiation. Rex1GFP-positive cells
from serum showed similar behavior to 2i cells (Figure 7B).
Downregulation of Nanog and Rex1 was followed by upregula-(B) Average profiles of H3K27me3 and Ezh2 associated with silencing as in (A). Figure S3G shows a biologi
TNGA 2i ES cells.
(C) Typical example of H3K27me3 and H3K36me3 (dense setting) profiles.
(D) H3K27me3 profiling for three different cell lines maintained and derived in either 2i or serum, as in (B
NOD_male, and NOD_female ES cells in 2i and E14, HM1, and RGD2 ES cells in serum.
(E) As in (B); H3K27me3 profiling in Rex1-positive and Rex1-negative serum ES cells.
(F) H3K27me3 and Ezh2 intensity plots of all promoters containing H3K27me3 at >3-fold over random distrib
E14-serum; 3,870 promoters are depicted in rows on the y axis.
(G) Typical examples showing H3K27me3 reduction in 2i as compared to serum.
(H) As in (F); promoter profiles for 2i ES cells adapted to serum and vice versa. Average profiles are plotted
See also Figure S3, Figure S4, and Table S4.
Cell 149, 590–6tion of the postimplantation epiblast
marker Fgf5. From 3 days onward,
Fgf5 was downregulated and first T
(Brachyury; although very minor as
compared to the Rex1-negative cells),
then mesoderm and endoderm lineage
markers Tbx6, Cxcr4, Sox17, and Gata4
appeared. This order is consistent with
the developmental progression from
blastocyst to gastrulation. In contrast,
Rex1GFP-negative cells exhibit acceler-
ated upregulation of T and Tbx6 consis-
tent with their partial differentiation and
the loss of self-renewal (Figure S2D).
DISCUSSION
High-resolution genome-wide analyses
have revealed that culture environments
impose distinctive transcriptional and ep-
igenomic properties on mouse ES cells.In total some 13,000 genes are transcribed at above background
levels (>0.2 RPKM). The corollary of this is that around half of
genes are effectively inactive. Therefore, undifferentiated ES
cells do not show promiscuous gene expression or global tran-
scriptional hyperactivity (Efroni et al., 2008). Nonetheless, the
pluripotent transcriptome displays a broad bandwidth; more
than 25% of active genes show 2-fold or greater differences
between 2i and serum. Around 1,400 genes, predominantly
associated with metabolic processes, are upregulated in 2i. In
contrast, KEGG analysis points to decreased expression in 2ical replicate analysis for the H3K27me3 profiles of
). H3K27me3 profiles were generated for TNGA,
ution in at least one of the conditions, TNGA-2i or
in the middle (gray: 2i; black: serum).
04, April 27, 2012 ª2012 Elsevier Inc. 597
Figure 5. Bivalency in 2i and Serum
(A) H3K27me3 and H3K4me3 intensity plots at the
promoters of all genes (sum of reads), ranked on highest to
lowest H3K27me3 values in TNGA-serum (blue). Density
plot of bivalent genes identified by Mikkelsen et al. (2007;
‘‘M’’) (gray).
(B) Overlap between the bivalent genes as described by
Mikkelsen et al. (2007), and the bivalent genes in serum
determined in this study (top) and between 2i and serum
(bottom).
(C) H3K27me3, H3K4me3, and Pol II intensity plots of all
promoters that are bivalent in TNGA serum (this study).
(D) Typical examples of bivalent genes.
See also Figure S6 and Table S5.of components that might drive differentiation, such as cell
communication, mitogen-activated protein kinase (MAPK), and
transforming growth factor b (TGFb and Wnt) pathways. Most598 Cell 149, 590–604, April 27, 2012 ª2012 Elsevier Inc.strikingly, many ectodermal and mesodermal
specification genes that exhibit significant
expression in serum are repressed in 2i. Low to
absent lineage-affiliated gene expression indi-
cates that multilineage priming is not an intrinsic
feature of self-renewing ES cells. Upregulation of
such genes in serum suggests that metastability
may be an induced condition rather than an
inherent property of pluripotent cells.
Some endodermal genes such as Hex retain
low-level expression in 2i. This may reflect the
potential to generate extraembryonic endoderm
(Canham et al., 2010). High levels of Prdm14,
which has been reported to repress extraembyr-
onic endoderm transcription factors (Ma et al.,
2011), may prevent full activation of this
program.
Importantly, ES cells transferred between 2i
and serum switch their transcriptional profile.
Thus a significant component of previously
described ES cell signatures reflects an induced
serum response. However, critical pluripotency
factors are transcribed at similar or only slightly
higher levels in 2i. The pluripotency repressors
Tcf3 (Wray et al., 2011) and components of the
NuRD complex (Kaji et al., 2006) are also ex-
pressed at comparable levels. A subset of
SCM factors are specifically upregulated in
serum, including the Id genes that are induced
by BMPs or fibronectin and are thought to
directly counter the effects of Erk activation
(Ying et al., 2003a). Increased Eras, shown to
be important for ES cell propagation (Takahashi
et al., 2003), and factors such as Sall4, Lin28,
and Utf1, may also contribute to reinforcing
self-renewal in the face of differentiation stimuli.
The conflict between pluripotency factors and
lineage specifiers results in metastability and
incipient differentiation in serum. It is suggested
that this ‘‘precarious balance’’ (Loh and Lim,2011) may reflect the circumstance in egg cylinder epiblast cells.
However, serum stimulation is an artifactual scenario that may
be far from representative of the spatiotemporal precision of
Cell 149, 590–604, April 27, 2012 ª2012 Elsevier Inc. 599
inductive stimuli in the embryo. To access postimplantation
definitive lineages, ES cells should pass through a phase equiv-
alent to egg cylinder epiblast (Rossant, 2008). Consistent with
this, Fgf5 is upregulated in EBs prior to definitive germ layer
markers. From 2i ES cells and the Rex1GFP-positive fraction
of serum ES cells, this process follows similar kinetics. Therefore
although serum induces transcriptional and epigenetic changes
and associated metastability, developmental potential within
the Rex1-positive compartment is not fundamentally altered.
This is substantiated by the capacity of ES cells from either
condition to contribute extensively to chimaeras. However,
a significant proportion of cells in serum lose expression of
Rex1 and of core pluripotency factors such as Nanog and Klf4.
They are developmentally more advanced and should be
considered distinct from ES cells even though they retain Oct4
(Smith, 2010).
Expression of many genes associated with metabolic and
biosynthetic processes is enriched in 2i. This is likely in large
part a response to absence of serum constituents, loss of
MAPK signaling, and inhibition of GSK3 and indicates that ES
cells have adaptable metabolomic capacity. Probably as a
consequence of low c-Myc, the cell-cycle inhibitors p16, p19,
and p21 are upregulated in 2i, even at the protein level (Fig-
ure S7D). Nonetheless, ES cells continue to proliferate rapidly,
reflecting their freedom from cyclin checkpoint control (Burdon
et al., 2002; Stead et al., 2002). These features can explain the
robust expansion of ES cells independent of serum factors and
likely underlie their latent tumorigenicity (Chambers and Smith,
2004).
In 2i and serum H3K4me3 peaks are globally similar in number
and intensity. In contrast, there is a striking difference in the
pattern of H3K27me3 deposition. This mark is present as
a lawn across intergenic regions and inactive genes (Figure 3C).
However, elevated deposits at promoters of repressed genes
are greatly diminished in 2i. The majority of these genes
show reduced rather than increased transcription in 2i. This
promoter-specific diminution in H3K27me3 is common to
multiple ES cell lines. The majority of these genes show reduced
rather than increased transcription in 2i. Ezh2 is localized less
intensely at promoters in 2i, which may underlie the selective
reduction in H3K27me3. Global levels of H3K27me3 are similar
in 2i and serum. Indeed, H3K27me3 is increased at satellites in
2i, indicating that these may serve as a sink. Notably, there is
no change in H3K9me3 over satellites (Figure S3C).
In 2i only around 1,000 genes have both H3K4me3 and
H3K27me3 marks, which argues against bivalency as a master
epigenetic blueprint. Nonetheless, most of the remaining biva-
lent genes can be classified as developmental. In serum, moreFigure 6. RNA Polymerase II Pausing in Naive ES Cells
(A) Averaged Pol II at promoters of Myc-targets upregulated in serum. The top c
points, and the variance, between 2i and serum.
(B) Pol II traveling ratio (a quantification of pause release) of the Myc targets upre
(C) Typical examples of two Myc target genes showing pause release of Pol II.
(D) Percentage of Myc targets among all genes (left) or among the genes higher
(E) Averaged profiles of the promoter region of genes that are more highly expre
(F) Averaged Pol II profiles for the same gene groups as in (E).
See also Figure S7.
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this is accompanied by a slight overall increase in expression,
although the majority remain silent or transcribed at very low
levels (Figure S6A). It is conceivable that although the local
levels of PRC2 and H3K27me3 are reduced in 2i, they remain
sufficient to repress transcription. It should be noted, however,
that ES cells lacking PRC2, PRC1, or both are viable and show
derepression of lineage-specific markers to only a low level
(Leeb et al., 2010). Our findings are thus in line with genetic
evidence that polycomb is not a central mechanism for silencing
gene expression in the naive state and only becomes critical
during differentiation.
RNA polymerase pausing has been identified by GRO-seq
analysis (Min et al., 2011) at variable extents at many genes in
ES cells cultured in serum. Our findings indicate that pausing is
more prevalent in 2i than serum. Induction of c-Myc in serum
may facilitate pause release at some loci. This is consistent
with recent evidence that Myc function is unnecessary in naive
ES cells but required in serum (Hishida et al., 2011). However,
many of the genes whose expression is most markedly upregu-
lated in serum, including germ layer specification factors, are not
reported Myc targets. Therefore additional mechanisms are
likely to control pause release in ES cells.
In mammals pluripotent cells harbor the germline and most
pluripotency factors are also key players in germ cell specifica-
tion and differentiation. It is interesting therefore that in
Caenorhabditis elegans and Drosophila, germline development
is dependent on transcriptional pausing mediated at the level
of pTEFb antagonism by Pie-1 and Pgc, respectively (Nakamura
and Seydoux, 2008). This raises the question of whether naive
ES cells might contain an analogous factor that interferes with
pTEFb to suppress transcriptional elongation. It will also be
revealing to determine whether Erk signaling may cause activa-
tion of pTEFb (Fujita et al., 2008; Lee et al., 2010).
Recruitment and pausing of RNA polymerase II with lack of
consolidated H3K27me3 silencing may constitute a potentiated
template for induction of lineage-specific transcription pro-
grams. Pausing may serve to minimize the effects of noise and
ensure rapid, coordinated, and synchronous gene induction in
response to developmental cues or extrinsic stimuli (Boettiger
and Levine, 2009; Nechaev and Adelman, 2011). Recent studies
also indicate that Pol II pausing inhibits nucleosome assembly
(Gilchrist et al., 2010) and could thereby influence histone modi-
fication profile. Interestingly, in Xenopus embryos H3K27me3
is not deposited during zygotic gene activation but is acquired
later and associated with spatial restriction of gene expression
(Akkers et al., 2009). In the mouse ICM, H3K27me localization
has not been determined, but various epigenetic silencingorner values represent the average log2-fold difference of the individual data
gulated in serum.
(>2-fold change) in serum or 2i (right).
ssed in 2i (left) or serum (right).
AB
Figure 7. Differentiation Kinetics/Potential of 2i and Serum ES Cells
(A) Monolayer neural differentiation of Sox1-GFP ES cells maintained in either 2i or serum.
(B) Embryoid body differentiation of cells maintained in 2i, and of Rex1-positive and Rex1-negative serum ES cells as sorted by FACS (Figure S2C). Expression
levels were determined by RT-qPCR.components appear to be expressed at low levels (Tang et al.,
2010).
Collectively the observations reported here yield insights into
the molecular underpinning of naive pluripotency and revise
previous assumptions derived from analysis of heterogeneous
and metastable serum-treated cultures. The findings provoke
questions about the regulation of gene expression in pluripotent
cells and the process of lineage specification. Transcriptionalpotentiation through promoter proximal pausing may play
a major role in the establishment and stable maintenance of
naive pluripotency. Currently there is great interest in isolating
human pluripotent stem cells in a naive state (Hanna et al.,
2010; Wang et al., 2011). The distinctive transcriptome and
epigenome characteristics of ground state mouse ES cells
may provide a valuable criterion against which to measure
such claims. In addition, these data sets provide a benchmarkCell 149, 590–604, April 27, 2012 ª2012 Elsevier Inc. 601
resource for analysis and modeling of gene expression control
during self-renewal and in the transition from naive pluripotency
to lineage commitment.EXPERIMENTAL PROCEDURES
Cell Culture and Methods
ES cells were cultured without feeders in the presence of leukemia inhib-
itory factor (LIF) either in Glasgow modification of Eagles medium (GMEM)
containing 10% fetal calf serum or in serum-free N2B27 supplemented
with MEK inhibitor PD0325901 (1 mM) and GSK3 inhibitor CH99021 (3 mM),
together known as 2i (Ying et al., 2008). E14Tg2a (E14), Rex1GFPd2
(RGD2, Rex1GFP), and HM1 are male ES cells of 129 background estab-
lished and maintained in serum without feeders. The serum-derived female
XT67E1 line is from a mixed 129 and PGK/C3H background (Penny et al.,
1996). TNGA female ES cells were derived and maintained in 2i from
embryos on a mixed strain 129 and C57BL/6 background heterozygous for
eGFP knock-in at the Nanog gene (Chambers et al., 2007). Female and
male ES cells from the nonobese diabetic (NOD) strain were derived and
maintained in 2i (Nichols et al., 2009). Chromatin immunoprecipitations
(ChIP) were performed as described (Marks et al., 2009). Cell sorting
(fluorescence-activated cell sorting [FACS]), immunoblotting, RNA isolation,
and cDNA synthesis were performed according to standard protocols
described in the Extended Experimental Procedures, which also lists anti-
bodies used.
Sequencing
DNA samples were prepared for sequencing by end repair of 20 ng DNA
as measured by Qubit (Invitrogen). Adaptors were ligated to DNA fragments,
followed by size selection (300 bp) and 14 cycles of PCR amplification.
Cluster generation and sequencing (36 bp) was performed with the Illumina
GenomeAnalyzer IIx (GAIIx) platform according to standard Illumina protocols.
The standard pipeline to generate the sequencing output files are described in
the Supplemental Information. All sequencing analyses were conducted
based on the Mus musculus NCBI m37 genome assembly (MM9; assembly
July 2007). Table S1 summarizes the sequencing output. All RNA-seq and
ChIP-seq data (FASTQ, BED, and WIG files) are present in the NCBI GEO
SuperSeries GSE23943.
RNA-Seq Analysis
To obtain RNA-Seq gene expression values (RPKM), we used Genomatix
(www.genomatix.de). Differential genes were called at a 2-fold difference
and p < 0.2 in a Student t test (among three biological replicates for both 2i
and serum). The identification of ncRNAs is described in the Extended Experi-
mental Procedures. GO and KEGG analysis was performedwith DAVID (http://
david.abcc.ncifcrf.gov/).
ChIP-Seq Analyses
To compensate for differences in sequencing depth and mapping efficiency,
the total number of unique reads of each sample was uniformly equalized,
allowing quantitative comparisons. Tag densities on the average profiles
were determined by calculating tag density over each base pair (using
a 40 bp window size) per 10 million total mapped reads. The genes used
for the average epigenetic profiles were based on the 2,000 most active/
inactive genes in TNGA-2i. The 2,000 lowest/not expressed genes were
selected by the additional requirement of H3K27me3 promoter enrichments
of > 3-fold over background in either TNGA-2i or E14-serum. Random
distribution values were determined by calculating average read densities
of the genomic DNA profile (4.962 reads/kb at 10 million sequenced reads
equivalent to an average density of 1.489 per bp). Genes were considered
bivalent if both H3K4me3 and H3K27me3 were > 3-fold over random
distribution, similar to criteria applied by Mikkelsen et al. (2007). The RNA
Polymerase II traveling was calculated as described by Rahl et al. (2010).
The Chip-seq repeat analysis procedure is described in the Supplemental
Information.602 Cell 149, 590–604, April 27, 2012 ª2012 Elsevier Inc.Differentiation Assays
For monolayer neural differentiation, we used Sox1-GFP (46C) ES cells, which
contain a GFP knock-in at the endogenous Sox1 locus (Ying et al., 2003b).
Cells cultured in 2i or serum were plated at a density of 5,000 cells per cm2.
Sixteen hours after plating, media were switched to N2B27 to induce neural
differentiation. Percentage of GFP-positive cells was determined by flow
cytometry. For EB differentiation, single EBs were formed by sorting 1,500
cells into each well of PrimeSurface96U plates containing 15% serum and
no LIF. Sixteen EBs were pooled each day and analyzed by RT-qPCR with
TaqMan probes (Applied Biosystems).
ACCESSION NUMBERS
The GEO accession number for the SuperSeries reported in this paper is
GSE23943.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and six tables and can be found with this article online at
doi:10.1016/j.cell.2012.03.026.
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